These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 239485)
1. The effects of sulphydryl reagents on the binding and mixed function oxidation of hexobarbital in rat hepatic microsomes. Paul H; Illing A; Netter KJ Xenobiotica; 1975 Jan; 5(1):1-15. PubMed ID: 239485 [TBL] [Abstract][Full Text] [Related]
2. Proceedings: The role of sulphydryl groups in microsomal mixed function oxidation of drugs. Illing HP; Puhalla G; Netter KJ Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R37. PubMed ID: 4276568 [No Abstract] [Full Text] [Related]
3. Effect of 2,4-dinitrophenol on the oxidative metabolism of hexobarbital by cytochrome P-450 in perfused rat liver. Suzaki T; Iyanagi T; Kobayashi S J Biochem; 1983 Aug; 94(2):361-71. PubMed ID: 6630164 [TBL] [Abstract][Full Text] [Related]
4. The differentiation of N-oxidation and N-dealkylation of N-ethyl-N-methylaniline by rabbit liver microsomes as distinct metabolic routes. Gorrod JW; Temple DJ; Beckett AH Xenobiotica; 1975 Aug; 5(8):465-74. PubMed ID: 241156 [TBL] [Abstract][Full Text] [Related]
5. Oxidation-reduction states of pyridine nucleotide and cytochrome P-450 during mixed-function oxidation in perfused rat liver. Iyanagi T; Suzaki T; Kobayashi S J Biol Chem; 1981 Dec; 256(24):12933-9. PubMed ID: 7309741 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of cytochrome P-450-dependent mixed function oxidation by ethanol. Hayashi N; Kamada T; Sato N; Kasahara A; Peterson JA Dig Dis Sci; 1985 Apr; 30(4):334-9. PubMed ID: 2983957 [TBL] [Abstract][Full Text] [Related]
7. Piperonyl butoxide metabolism by cytochrome P-450: factors affecting the formation and disappearance of the metabolite-cytochrome P-450 complex. Franklin MR Xenobiotica; 1972 Nov; 2(6):517-27. PubMed ID: 4145693 [No Abstract] [Full Text] [Related]
8. Doxapram inhibits the in vitro oxidation of hexobarbital. Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):371-4. PubMed ID: 1719592 [TBL] [Abstract][Full Text] [Related]
9. Calculation of competitive inhibition of substrate binding to cytochrome P-450 illustrated by the interaction of d,l-propranolol with d,l-hexobarbital. Bast A; Noordhoek J Biochem Pharmacol; 1980 Mar; 29(5):747-51. PubMed ID: 20227951 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of nilutamide, a new androgen receptor antagonist, on mouse and human liver cytochrome P-450. Babany G; Tinel M; Letteron P; Freneaux E; Berson A; Larrey D; Pessayre D Biochem Pharmacol; 1989 Mar; 38(6):941-7. PubMed ID: 2930595 [TBL] [Abstract][Full Text] [Related]
11. [Hexobarbital-oxidation in vivo and in vitro in rats after phenobarbital-pretreatment or after portacaval anastomosis (author's transl)]. Richter E; Gallenkamp H; Brachtel D; Grün M Z Gastroenterol; 1977 Jun; 15(6):389-92. PubMed ID: 888489 [TBL] [Abstract][Full Text] [Related]
12. Direct effect of carbon monoxide on hexobarbital metabolism in the isolated perfused liver in the absence of hemoglobin. Takano T; Motohashi Y; Miyazaki Y; Okeda R J Toxicol Environ Health; 1985; 15(6):847-54. PubMed ID: 4057285 [TBL] [Abstract][Full Text] [Related]
13. Heme enhances hexobarbital metabolism in perfused rat liver after drug-mediated destruction of cytochrome P-450. Farrell GC; Gollan JL; Correia MA; Schmid R J Pharmacol Exp Ther; 1981 Aug; 218(2):363-7. PubMed ID: 7252836 [TBL] [Abstract][Full Text] [Related]
14. Protection of hexaprenyl-diphosphate synthase of Micrococcus luteus B-P 26 against inactivation by sulphydryl reagents and arginine-specific reagents. Yoshida I; Koyama T; Ogura K Biochim Biophys Acta; 1989 Apr; 995(2):138-43. PubMed ID: 2539196 [TBL] [Abstract][Full Text] [Related]
15. The binding of hexobarbital and aniline to cytochrome P-450 of liver microsomes from control and phenobarbital-treated rats of different ages. Müller D; Klinger W Acta Biol Med Ger; 1976; 35(5):627-33. PubMed ID: 983613 [TBL] [Abstract][Full Text] [Related]
16. The enzymic formation of methylenedioxyphenyl derivative exhibiting an isocyanide-like spectrum with reduced cytochrome P-450 in hepatic microsomes. Franklin MR Xenobiotica; 1971 Nov; 1(6):581-91. PubMed ID: 4154538 [No Abstract] [Full Text] [Related]
17. Hexobarbital-binding, hydroxylation and hexobarbital-dependent hydrogen peroxide production in hepatic microsomes of guinea pig, rat and rabbit. Heinemeyer G; Nigam S; Hildebrandt AG Naunyn Schmiedebergs Arch Pharmacol; 1980 Nov; 314(2):201-10. PubMed ID: 7453835 [TBL] [Abstract][Full Text] [Related]
18. A new spectral intermediate associated with cytochrome P-450 function in liver microsomes. Estabrook RW; Hildebrandt AG; Baron J; Netter KJ; Leibman K Biochem Biophys Res Commun; 1971 Jan; 42(1):132-9. PubMed ID: 4396002 [No Abstract] [Full Text] [Related]
19. Growth hormone modulation of liver drug metabolic enzyme activity in the rat. I. Effect of the hormone on the content and rate of reduction of microsomal cytochrome P-450. Wilson JT Biochem Pharmacol; 1973 Jul; 22(14):1717-28. PubMed ID: 4146051 [No Abstract] [Full Text] [Related]
20. [Changes in testosterone oxidation in rat liver microsomes after prolonged administration of ethylmorphine]. Pospelova LN; Chistiakov VV Biokhimiia; 1981 Feb; 46(2):347-52. PubMed ID: 7248389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]